Tianqi Lithium Corporation (09696) is expected to make a total provision for asset impairment of approximately RMB 2.163 billion in 2024.
Tianqi Lithium (09696) announced that the company started the "..." project in Australia in 2016 and 2017 respectively.
Tianqi Lithium Corporation (09696) announced that it initiated construction-related work for the "annual production of 24,000 tons of battery-grade lithium hydroxide monohydrate project" and "second phase annual production of 24,000 tons of battery-grade lithium hydroxide monohydrate project" in Australia in 2016 and 2017 respectively. Currently, the first-phase lithium hydroxide project is in the capacity climbing phase, while the second-phase project is in a temporary halt phase.
In accordance with the relevant regulations of the Chinese Enterprise Accounting Standards and other systems, the company is conducting impairment testing on the above-mentioned lithium hydroxide projects based on the latest situation, and is in continuous communication with the management of its subsidiary, Tianqi Lithium Energy Australia Pty Ltd ("TLEA"). Based on preliminary calculations, the company estimates a total provision of approximately RMB 1.412 billion for impairment of construction in progress and right-of-use assets in 2024 (excluding the first-phase lithium hydroxide project, if any).
In accordance with the Chinese Enterprise Accounting Standards, company accounting policies, and other related systems, and based on the principle of prudence, the company and its subsidiaries are conducting a comprehensive and thorough inventory, analysis, and evaluation of relevant assets to accurately reflect the financial condition, asset value, and operating results as of December 31, 2024. After impairment testing on assets that may indicate impairment by December 31, 2024, it is estimated that a total provision of approximately RMB 2.163 billion for asset impairment will be made (excluding the first-phase lithium hydroxide project, if any).
Related Articles

China Securities International: Commercial and industrial clients have location advantages, expected growth in sales volume for Tian Lun Gas (01600) in the first quarter.

HK Stock Market Move | The concept of innovative drugs is generally getting stronger, with policy support for the full development of the innovative drug chain. Institutions describe innovative drugs as still being one of the important investment themes.

HK Stock Market Move | XIAOMI-W(01810) fell over 4% in early trading, Lei Jun responded that the proportion of SU7 and SU7 Ultra converted to YU7 is less than 15%.
China Securities International: Commercial and industrial clients have location advantages, expected growth in sales volume for Tian Lun Gas (01600) in the first quarter.

HK Stock Market Move | The concept of innovative drugs is generally getting stronger, with policy support for the full development of the innovative drug chain. Institutions describe innovative drugs as still being one of the important investment themes.

HK Stock Market Move | XIAOMI-W(01810) fell over 4% in early trading, Lei Jun responded that the proportion of SU7 and SU7 Ultra converted to YU7 is less than 15%.

RECOMMEND

U.S. Senate Passes “Big and Beautiful” Bill, Triggering Surge in Gold Amid Soaring Deficit Concerns
02/07/2025

Declining Demand Triggers Price Drop; Photovoltaic Glass Industry May Be Preparing for a New Round of Coordinated Production Cuts
02/07/2025

Surge in Prices of Chinese-Made Goods Highlights Tariff Impact on U.S. Consumers
02/07/2025